EchoSolv AS vs ElucidVivo A.3
AI Verdict
Choose EchoSolv AS if…
Choose EchoSolv AS if your primary need is to quickly and accurately identify patients at high risk for severe aortic stenosis using existing echocardiogram measurements. This tool is ideal for enhancing clinical workflow efficiency by providing rapid, AI-powered decision support and helping prioritize studies for closer review, without requiring EMR integration.
View EchoSolv AS →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if you require detailed, quantitative analysis of arterial plaque composition and stability from CT angiography to stratify atherosclerosis patients and optimize treatment decisions. This system excels at providing granular insights into plaque characteristics, including lipid-rich necrotic core and calcifications, and offers advanced 3D visualization for comprehensive cardiovascular risk assessment.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | ElucidVivo A.3 |
|---|---|---|
| Deployment | Cloud-based | Cloud and on-premise secure deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoSolv ASEchoSolv AS emphasizes seamless integration into existing PACS workflows without requiring EMR integration, and boasts ultra-fast risk detection in under 3 seconds. This focus on minimal disruption and rapid results suggests a higher degree of immediate usability and easier adoption for clinicians. ElucidVivo A.3, while offering rich visualizations, does not explicitly highlight the same level of workflow simplicity or speed for direct user interaction.
Clinical Value
ElucidVivo A.3ElucidVivo A.3 provides comprehensive quantitative analysis of arterial plaque composition and stability, including Lipid-Rich Necrotic Core (LRNC) and FFRct derivation, validated against ground-truth histology. This offers deeper, more nuanced insights into atherosclerosis, a broader cardiovascular disease, and has demonstrated a 40% improvement in predictive accuracy for events like stroke. While EchoSolv AS is highly accurate for severe aortic stenosis, ElucidVivo A.3's broader and more detailed diagnostic capabilities, backed by histology validation, offer superior clinical value.
Pricing & Value
ElucidVivo A.3ElucidVivo A.3 has a more established reimbursement pathway, with a Category I CPT code for coronary plaque analysis going into effect soon and existing coverage by a major insurer like United Healthcare. This transparency and established mechanism provide a clearer financial value proposition for healthcare providers. EchoSolv AS has identified a miscellaneous code and is pursuing a Category III CPT code, but its reimbursement landscape is less mature.
Enterprise Readiness
EchoSolv ASEchoSolv AS explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in the provided structured facts, which are critical for enterprise adoption in healthcare. Its cloud-based deployment and design to fit existing PACS workflows without EMR integration further enhance its readiness. While ElucidVivo A.3 mentions 'HIPAA-aligned data protection' in some sources, the explicit declarations for Tool A provide more immediate assurance.
Innovation
ElucidVivo A.3ElucidVivo A.3 demonstrates greater innovation by offering 'CT Virtual Histologyu2122' through quantitative analysis of arterial plaque composition and stability, validated against ground-truth histology. Its ability to non-invasively quantify specific plaque components like LRNC and derive FFRct from CT angiography represents a significant advancement in understanding and managing atherosclerosis. EchoSolv AS's measurement-based AI is clever but less groundbreaking in comparison.
Support & Docs
EchoSolv ASEchoSolv AS explicitly mentions a 'Clinician user manual' and a 'suite of supporting documentation' to assist with reimbursement, along with 'Feedback & Support' sections on its website. This indicates a more structured approach to providing resources and assistance to users. For ElucidVivo A.3, specific details on user manuals, training, or dedicated support channels are not readily available in the provided information or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | ElucidVivo A.3 |
|---|---|---|
| Name | EchoSolv AS | ElucidVivo A.3 |
| Company | Echo IQ | Elucid Bioimaging |
| Description | FDA-cleared, AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology. |
| Primary Focus | Identifying patients at risk for severe aortic stenosis from echocardiograms. | Quantitative analysis of arterial plaque composition and stability from CT angiography. |
| Key Features (Examples) | AI-powered clinical decision support for severe aortic stenosis probability, consistent severe AS probability and guideline check from measurements, second reader support to help prioritize studies for closer review. | AI-powered quantitative analysis of arterial plaque, objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition. |
| Specialties | Cardiology, Cardiothoracic Surgery | Cardiology, Radiology, Vascular Surgery |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and ElucidVivo A.3.